Statera Biopharma, Lay Sciences announce intent to enter strategic partnership
Statera Biopharma has announced its intent to enter into a non-binding term sheet with regard to a strategic partnership with Lay Sciences, a development and commercialisation company of innovative solutions to license global manufacturing rights to some of Lay Sciences’ IgY products featuring avian antibodies as an active ingredient.